Latest / Through the Line: Packaging and Processing / FDA Priorities for Advancing Food Safety in 2026: ProFood World

Transcript

FDA Priorities for Advancing Food Safety in 2026: ProFood World · Through the Line: Packaging and Processing

• 0:03
  SPEAKER_00: Welcome to Through the Line, the podcast exploring innovations and information across the packaging and processing landscape.
• 0:11
  SPEAKER_00: From topics impacting consumer packaged goods and healthcare packaging to the latest technologies in food processing operations.
• 0:22
  SPEAKER_02: Hi, I'm Casey Flanagan, Associate Editor with ProFood World.
• 0:25
  SPEAKER_02: This AI-generated podcast episode explores the FDA's 2026 priorities for food safety, emphasizing a shift toward a data-driven, prevention-centered oversight model.
• 0:35
  SPEAKER_02: We'll discuss the agency's focus on food safety modernization act enforcement, allergen control, and chemical hazards and food safety culture.
• 0:43
  SPEAKER_02: It outlines how manufacturers can transition from baseline compliance to fully integrated, transparent safety systems to meet evolving regulatory expectations.
• 0:52
  SPEAKER_03: So this deep dive is really about unpacking the FDA's 2026 priorities for the Human Foods Program, which is basically preparing packaging and processing professionals for this entirely new era of food safety.
• 1:06
  SPEAKER_03: And it's all driven by data prevention and supply chain transparency.
• 1:10
  SPEAKER_01: It's a massive shift.
• 1:11
  SPEAKER_03: Imagine a single microscopic pathogen gets swabbed from a floor drain in your facility this morning.
• 1:18
  SPEAKER_01: Just a standard Tuesday swab.
• 1:19
  SPEAKER_03: And then imagine that exact same pathogen being instantly linked to a consumer illness like 500 miles away by tomorrow afternoon.
• 1:26
  SPEAKER_01: It sounds wild, but it's really happening.
• 1:28
  SPEAKER_03: Yeah.
• 1:29
  SPEAKER_03: That level of tracking is absolutely not science fiction anymore.
• 1:32
  SPEAKER_03: It is the FDA's actual 2026 playbook.
• 1:35
  SPEAKER_03: Welcome to our deep dive into the agency's newly reorganized human foods program priorities.
• 1:40
  SPEAKER_01: Glad to be here for this one.
• 1:41
  SPEAKER_01: It's so critical.
• 1:42
  SPEAKER_03: Aaron Powell We are tailoring this entire analysis specifically for you, the listener, whether you're in packaging, processing, or you're a food manufacturing professional out there operating on the front lines.
• 1:50
  SPEAKER_01: Aaron Powell Because you're the ones who actually have to implement this stuff, right?
• 1:52
  SPEAKER_03: Aaron Ross Powell Exactly.
• 1:53
  SPEAKER_03: Our overarching mission today is to distill our source document and explore exactly what these impending regulatory shifts actually mean for your daily operations and your strategic planning.
• 2:05
  SPEAKER_01: Aaron Powell Yeah.
• 2:05
  SPEAKER_01: And the big overarching theme here is that the FDA is moving decisively, very decisively, beyond baseline compliance.
• 2:14
  SPEAKER_01: We are looking at a completely new standard now.
• 2:17
  SPEAKER_01: It requires fully integrated, data-informed programs that actually support continuous improvement.
• 2:23
  SPEAKER_03: Aaron Powell So for you listening, this means a shift from simply having safety protocols written down and some binder collecting dust to scientifically proving they work in real time.
• 2:32
  SPEAKER_01: Aaron Powell Yeah, you can't just check the box anymore.
• 2:34
  SPEAKER_01: The agency is taking the really hard lessons they learn from these massive supply chain disruptions and recent large-scale outbreaks, and they are applying those lessons directly to the manufacturing floor.
• 2:44
  SPEAKER_03: Aaron Powell Which means we really need to look at how the FDA is physically inspecting facilities today.
• 2:49
  SPEAKER_01: Aaron Powell Absolutely.
• 2:50
  SPEAKER_01: The enforcement of FSMA, the Food Safety Modernization Act, it is intensifying specifically around preventive controls for human food.
• 2:58
  SPEAKER_03: Aaron Powell So inspectors aren't just walking in and saying, hey, do you have a hazard analysis?
• 3:02
  SPEAKER_01: Aaron Powell No, not at all.
• 3:03
  SPEAKER_01: They are demanding scientific validation of your controls.
• 3:07
  SPEAKER_01: So that means your process, your sanitation, and your supply chain controls all need hard proof.
• 3:12
  SPEAKER_03: Aaron Powell I like to think of it like this.
• 3:14
  SPEAKER_03: It is the difference between just installing a smoke detector in your house and actually showing the auditor the exact log where you regularly test it with actual smoke.
• 3:24
  SPEAKER_01: Aaron Powell That's a great way to put it.
• 3:25
  SPEAKER_01: They want undeniable proof of effectiveness, not just the hardware.
• 3:28
  SPEAKER_03: Aaron Powell And when we look at environmental monitoring, the regulatory focus there is incredibly sharp right now.
• 3:34
  SPEAKER_01: Oh yeah.
• 3:35
  SPEAKER_01: Regulators are hunting for very specific pathogens.
• 3:38
  SPEAKER_01: Primarily, they're looking for salmonella, Listeria monocytogens, and Escherichia coli.
• 3:43
  SPEAKER_03: E.
• 3:43
  SPEAKER_03: coli is always a big one.
• 3:44
  SPEAKER_01: Always.
• 3:45
  SPEAKER_01: And this scrutiny is intense, especially for high-risk categories like exposed RTE, meaning ready-to-eat foods.
• 3:52
  SPEAKER_03: Aaron Powell Because there's no kill step left for the consumer, right?
• 3:55
  SPEAKER_01: Exactly.
• 3:55
  SPEAKER_01: So inspectors are meticulously evaluating your physical facility zoning, your sanitation procedures, and employee hygiene.
• 4:02
  SPEAKER_03: Aaron Powell But the most significant change in their enforcement capabilities, I think, really comes down to the aggressive use of whole genomes to link these facilities to illness clusters.
• 4:13
  SPEAKER_01: Yeah, whole genome sequencing is a total game changer.
• 4:15
  SPEAKER_03: Aaron Powell So how does this specific tool actually change the mechanics and the speed of a modern FDA investigation for a processing plant?
• 4:24
  SPEAKER_01: Aaron Powell Whole genome sequencing completely removes all that epidemiological guesswork that used to define outbreak investigations.
• 4:30
  SPEAKER_03: Aaron Powell What do you mean by guesswork?
• 4:32
  SPEAKER_01: Think of it like upgrading from a blurry black and white security camera photo to having the suspect's exact DNA and fingerprints.
• 4:40
  SPEAKER_01: Yeah.
• 4:40
  SPEAKER_01: Because in the past, matching a sick consumer to a specific processing plant took weeks.
• 4:44
  SPEAKER_01: It was so slow.
• 4:45
  SPEAKER_03: They had to do those huge surveys.
• 4:47
  SPEAKER_01: Exactly.
• 4:48
  SPEAKER_01: It relied on interviewing patients about what they ate, finding commonalities, and then initiating these broad, highly disruptive product recalls just hoping they caught the right product.
• 4:57
  SPEAKER_03: Aaron Powell Which is a nightmare for everyone involved.
• 4:59
  SPEAKER_01: Complete nightmare.
• 5:00
  SPEAKER_01: Now, if an outbreak occurs, the FDA simply sequences the pathogen isolated from the patient and compares it directly to a pathogen swabbed from a processing facility.
• 5:10
  SPEAKER_03: Aaron Powell And if those genetic sequences match, the link is just scientifically undeniable.
• 5:14
  SPEAKER_03: Trevor Burrus, Jr.
• 5:14
  SPEAKER_01: Undeniable.
• 5:15
  SPEAKER_01: The lag time in outbreak detection practically vanishes.
• 5:19
  SPEAKER_01: It is.
• 5:19
  SPEAKER_01: And the thing is, the FDA is actively building this massive genomic database.
• 5:24
  SPEAKER_03: They're storing all this data.
• 5:26
  SPEAKER_01: Yes.
• 5:26
  SPEAKER_01: So if you have a resident pathogen surviving in a tiny overlooked niche within your facility, like a microscopic crack in a floor drain, or maybe a poorly sealed gasket on a mixer, the FDA will eventually find it.
• 5:40
  SPEAKER_03: And once they sequence it, boom, it goes into the database forever.
• 5:42
  SPEAKER_01: Aaron Ross Powell Exactly.
• 5:43
  SPEAKER_01: So if an illness pops up months later that matches that sequence, they will trace it back to your facility with absolute certainty.
• 5:49
  SPEAKER_03: Aaron Powell So you can't just hide behind the complexity of the supply chain anymore.
• 5:53
  SPEAKER_01: Not at all.
• 5:55
  SPEAKER_01: This is exactly why aggressive internal environmental monitoring and rapid response protocols are absolute necessities now.
• 6:02
  SPEAKER_03: Aaron Ross Powell You have to find the pathogen and basically eradicate it before the regulatory swab finds it.
• 6:08
  SPEAKER_01: That's the only way.
• 6:09
  SPEAKER_03: So, okay, if the FDA can find a pathogen in a matter of minutes and instantly trace it to its source, I imagine they expect manufacturers to be able to trace their products and ingredients through the supply chain just as fast.
• 6:20
  SPEAKER_01: Oh, 100%.
• 6:21
  SPEAKER_01: That causal link is exactly what drives the strict new digital traceability rule.
• 6:27
  SPEAKER_03: Which is a massive part of this.
• 6:28
  SPEAKER_03: Compliance with the FSMA food traceability rule is explicitly a major 2026 regulatory priority.
• 6:35
  SPEAKER_01: Yeah.
• 6:35
  SPEAKER_01: And our source document outlines mandatory end-to-end data capture at very defined tracking points.
• 6:41
  SPEAKER_03: And the FDA targets specific foods on the food traceability list.
• 6:45
  SPEAKER_03: They didn't just pick these out of a hat, right?
• 6:47
  SPEAKER_01: No, they didn't select these items at random at all.
• 6:50
  SPEAKER_01: They targeted items that share a history of rapid spoilage or ones that lack a kill step before consumption.
• 6:55
  SPEAKER_03: Like we were saying earlier, if contamination happens in these categories, there is literally no safety net like cooking to eliminate the hazard before someone eats it.
• 7:05
  SPEAKER_01: Exactly.
• 7:06
  SPEAKER_01: The logic behind the list is purely risk-based.
• 7:09
  SPEAKER_01: So we are talking about things like soft and semi-soft, unpasteurized cheeses, shell eggs, and both raw and roasted forms of nuts and nut butters.
• 7:19
  SPEAKER_03: Basically everything that's notoriously tricky.
• 7:21
  SPEAKER_03: What about produce?
• 7:22
  SPEAKER_01: Fresh produce is heavily scrutinized.
• 7:25
  SPEAKER_01: Specifically, they are looking at leafy greens, cucumbers, tomatoes, and cut fruit.
• 7:29
  SPEAKER_03: Seafood is also on the list, right?
• 7:31
  SPEAKER_01: Yep.
• 7:31
  SPEAKER_01: It covers fresh, frozen and smoked finfish, crustaceans, and mollusks alongside ready-to-eat deli salads.
• 7:37
  SPEAKER_03: Wait, ready-to-eat deli salads, like macaroni salad or potato salad.
• 7:41
  SPEAKER_01: Exactly.
• 7:42
  SPEAKER_01: Because of the mixing of ingredients and the high moisture, they're super high risk.
• 7:46
  SPEAKER_01: So for every single one of these products, the FDA requires detailed, precise record keeping.
• 7:51
  SPEAKER_03: Aaron Powell, which means paper isn't going to cut it anymore.
• 7:53
  SPEAKER_01: Definitely not.
• 7:54
  SPEAKER_01: They expect manufacturers to implement digital interoperable systems to manage this vast amount of data.
• 8:00
  SPEAKER_01: The traditional paper-based processes simply lack the speed and accuracy required during urgent product recalls.
• 8:06
  SPEAKER_03: Okay, but let me play devil's advocate here for a second, pushing back on behalf of some of the smaller manufacturing listeners out there.
• 8:12
  SPEAKER_03: Let's say a facility has this perfectly organized, pristine paper logging system.
• 8:19
  SPEAKER_03: They have utilized it flawlessly for decades.
• 8:22
  SPEAKER_03: If the system is accurate and the staff knows exactly how to use it, why is the FDA essentially forcing a costly transition to digital interoperability?
• 8:33
  SPEAKER_01: It's a fair question and a common one.
• 8:35
  SPEAKER_01: But look at it this way: a pristine paper log might serve a single facility really well during a routine internal audit.
• 8:41
  SPEAKER_01: But recalls do not happen in an isolated vacuum?
• 8:44
  SPEAKER_01: Think about a multi-state outbreak involving a highly perishable product like leafy greens.
• 8:49
  SPEAKER_01: Okay.
• 8:49
  SPEAKER_01: You have a farm in California, a processor in Arizona, a distributor in Texas, and a retailer in New York.
• 8:55
  SPEAKER_03: That's a huge way.
• 8:56
  SPEAKER_01: So if your pristine paper log has to be physically located in a filing cabinet, then someone has to manually scan it, email it as a static PDF, and then someone in Texas has to manually decipher it and re-enter it into their distributor database.
• 9:10
  SPEAKER_03: You're losing precious hours at every single node.
• 9:13
  SPEAKER_01: Exactly.
• 9:14
  SPEAKER_01: And when the FDA is trying to pull toxic food off store shelves, every single hour directly impacts public health.
• 9:21
  SPEAKER_03: You can't be waiting on a fax or an email attachment.
• 9:24
  SPEAKER_01: An interoperable digital system allows that critical traceability data to flow seamlessly and instantaneously between all supply chain partners and regulatory bodies.
• 9:35
  SPEAKER_03: So public health emergencies essentially require instantaneous, frictionless data integration.
• 9:40
  SPEAKER_01: Exactly.
• 9:40
  SPEAKER_01: Which siloed paper systems fundamentally cannot provide under the pressure of a real-time recall.
• 9:46
  SPEAKER_03: That makes total sense.
• 9:47
  SPEAKER_03: Now traceability is crucial for mitigating damage when something goes wrong, obviously.
• 9:51
  SPEAKER_03: But the FDA's ultimate goal is stopping hazards before they ever have the chance to leave the facility.
• 9:56
  SPEAKER_01: Prevention is the whole point of FSMA.
• 9:58
  SPEAKER_03: And this pivot to prevention is especially critical for immediate life-threatening hazards like undeclared allergens.
• 10:06
  SPEAKER_01: Absolutely.
• 10:06
  SPEAKER_01: If a facility gets an environmental or product-posit result now, the FDA expects a rigorous, science-based root cause analysis.
• 10:16
  SPEAKER_03: To really address the underlying system weaknesses.
• 10:18
  SPEAKER_01: Yes.
• 10:19
  SPEAKER_01: You must document corrective and preventative actions and link them directly to the initial findings to strengthen the overall food safety plan.
• 10:26
  SPEAKER_03: Why is that root cause analysis so paramount?
• 10:29
  SPEAKER_01: Because a positive environmental swab is merely a symptom of a larger systemic failure.
• 10:34
  SPEAKER_03: It's just the tip of the iceberg.
• 10:36
  SPEAKER_01: So if your response is to simply sanitize the specific floor drain where the positive swab occurred, but you fail to investigate how the pathogen physically entered that zone in the first place, you haven't actually fixed the problem.
• 10:47
  SPEAKER_03: You just cleaned up the mess for today.
• 10:49
  SPEAKER_01: Exactly.
• 10:49
  SPEAKER_01: Did it come in on the wheels of a forklift?
• 10:52
  SPEAKER_01: Did an employee bypass a sanitation footbath?
• 10:55
  SPEAKER_01: You have to identify the actual vector.
• 10:57
  SPEAKER_03: And the FDA expects to see documented proof that you asked those exact questions and implemented a permanent structural or procedural fix.
• 11:05
  SPEAKER_01: They want to see the thought process, yeah.
• 11:07
  SPEAKER_03: So pivoting slightly to allergens, our source document explicitly flags allergen management as a leading enforcement priority.
• 11:14
  SPEAKER_01: Yes.
• 11:15
  SPEAKER_01: Allergens are foreseeable hazards.
• 11:17
  SPEAKER_01: They require risk-based preventive controls to stop cross-contact.
• 11:21
  SPEAKER_03: However, labeling errors still remain a leading cause of product recalls, which is wild to me.
• 11:26
  SPEAKER_01: It's true.
• 11:27
  SPEAKER_01: Manufacturers are required to maintain robust label review processes to ensure product formulations perfectly match the printed ingredient declarations.
• 11:36
  SPEAKER_03: But practically speaking, how does a packaging professional actually ensure that a sudden, minor formulation change occurring way over on the processing floor instantly translates to the correct physical label on a high-speed packaging line?
• 11:50
  SPEAKER_01: It's tough, but ensuring that accuracy requires a fully synchronized closed loop system between product development, floor operations, and the packaging department.
• 11:59
  SPEAKER_03: So no more silos.
• 12:00
  SPEAKER_01: A packaging professional cannot operate in an isolated silo anymore.
• 12:05
  SPEAKER_01: Consider a real-world scenario where an alternative ingredient must be substituted on the processing floor due to a sudden supply chain shortage.
• 12:13
  SPEAKER_03: Which happens all the time now.
• 12:15
  SPEAKER_01: Perhaps the mixing operator has to swap a different type of thickener or add a slightly different preservative blend that happens to contain a soy derivative.
• 12:24
  SPEAKER_03: Oh, and soy is a major allergen.
• 12:26
  SPEAKER_01: Exactly.
• 12:27
  SPEAKER_01: That physical substitution on the floor must trigger an immediate automated halt at the packaging line.
• 12:33
  SPEAKER_03: Wait, really?
• 12:33
  SPEAKER_03: The whole line stops.
• 12:35
  SPEAKER_01: Yes.
• 12:35
  SPEAKER_01: The labeling machinery literally cannot resume until the new legally compliant label is verified, loaded, and audited.
• 12:43
  SPEAKER_01: Wow.
• 12:44
  SPEAKER_01: The FDA expects a robust review process that mandates a final physical verification step.
• 12:50
  SPEAKER_01: The actual signed formulation record for the specific batch currently running in the VAT must be strictly cross-referenced against the physical label being applied by the machinery.
• 12:58
  SPEAKER_03: Because the risk of human error is just too high.
• 13:00
  SPEAKER_01: Exactly, which is why integrated software and aggressively enforced operational procedures are vital to remove any possibility of miscommunication.
• 13:08
  SPEAKER_01: You can't rely on someone just remembering to tell the packaging guy.
• 13:11
  SPEAKER_03: That makes a lot of sense.
• 13:12
  SPEAKER_01: Yeah.
• 13:13
  SPEAKER_03: So while undeclared allergens present an acute, immediate physical hazard, the FDA is also significantly expanding its regulatory focus to include long-term systemic hazards.
• 13:25
  SPEAKER_01: Yes, this is a big shift.
• 13:27
  SPEAKER_03: Specifically, they are looking closely at chemical contaminants and toxic elements.
• 13:32
  SPEAKER_03: And this shift directly changes how the agency scores and schedules facility inspections.
• 13:37
  SPEAKER_01: Yeah, there is a marked increase in scrutiny regarding your sourcing practices, your internal testing programs, and your supplier controls.
• 13:44
  SPEAKER_03: The hazards of high concern are pretty varied here.
• 13:47
  SPEAKER_03: Our source document lists naturally occurring environmental metals like arsenic in rice and rice products, and lead, which may be present in soil, water, and various imported foods.
• 13:57
  SPEAKER_01: Cadmium is also a major concern, accumulating in leafy greens, root vegetables, and shellfish, alongside mercury in seafood.
• 14:05
  SPEAKER_03: And they are also tracking pesticide residues originating from broad agricultural use.
• 14:10
  SPEAKER_01: Plus, beyond environmental factors, they are scrutinizing process-created chemicals.
• 14:14
  SPEAKER_03: Like what?
• 14:15
  SPEAKER_01: This includes acrylamide, which is formed naturally in fried or baked starchy foods, and feron, which is formed during heat processing applications.
• 14:24
  SPEAKER_01: Additives, including preservatives, colorants, and sweeteners, are also under tight review.
• 14:29
  SPEAKER_03: Okay, so here's a challenging question for you.
• 14:31
  SPEAKER_03: How can a processing professional realistically manage and be held fully accountable for a hazard like lead or cadmium that originates naturally in the soil at the farm level long before the raw ingredient ever reaches their facility?
• 14:45
  SPEAKER_01: That's the million-dollar question.
• 14:46
  SPEAKER_01: But from the FDA's perspective, the manufacturer or processor is considered the ultimate gatekeeper before the finished product reaches the consumer.
• 14:54
  SPEAKER_03: The buck stops with you.
• 14:56
  SPEAKER_01: Precisely.
• 14:56
  SPEAKER_01: You manage these complex soil level hazards through enhanced supplier oversight and rigorous testing specifications.
• 15:03
  SPEAKER_03: Even if the farm is in another country.
• 15:05
  SPEAKER_01: Yes.
• 15:06
  SPEAKER_01: You cannot control the heavy metal composition of the soil on a farm halfway across the world, but you retain absolute control over whether your company purchases crops from that specific farm.
• 15:17
  SPEAKER_03: Ah, procurement power.
• 15:19
  SPEAKER_01: Exactly.
• 15:19
  SPEAKER_01: A processing professional must demand detailed certificates of analysis or COAs from their suppliers for every single batch of high-risk ingredients.
• 15:29
  SPEAKER_03: But wait, can't suppliers just fake those or use outdated data?
• 15:33
  SPEAKER_01: That's exactly why blind trust in a certificate is no longer considered compliance.
• 15:38
  SPEAKER_01: You must independently verify those certificates through your own risk-based internal testing programs.
• 15:43
  SPEAKER_03: Ah, trust but verify.
• 15:45
  SPEAKER_01: Exactly.
• 15:46
  SPEAKER_01: If a supplier cannot consistently meet your strict safety specifications for lead or cadmium levels, you must disqualify them and find a safer source.
• 15:55
  SPEAKER_03: So the FDA expects your hazard risk assessments to actively address these toxic elements based on current scientific data?
• 16:01
  SPEAKER_01: Yes.
• 16:01
  SPEAKER_01: And crucially, they expect to see the documented proof showing you have actually rejected incoming ingredients that failed to meet those safety thresholds.
• 16:08
  SPEAKER_03: Oh, so rejecting a bad batch is actually good proof.
• 16:11
  SPEAKER_01: Yes.
• 16:12
  SPEAKER_01: It proves your system works.
• 16:13
  SPEAKER_01: The regulatory accountability lies entirely in your procurement standards and your verification testing.
• 16:18
  SPEAKER_03: Wow.
• 16:19
  SPEAKER_03: Okay.
• 16:20
  SPEAKER_03: To effectively manage these highly complex, diverse hazards, the FDA is adopting a fully data-driven, risk-based inspection model, right?
• 16:28
  SPEAKER_01: They are.
• 16:29
  SPEAKER_01: The frequency and the operational depth of an FDA inspection will be directly influenced by a facility specific product risk profile.
• 16:38
  SPEAKER_03: And their historical compliance record, too, I imagine.
• 16:40
  SPEAKER_01: Yep.
• 16:41
  SPEAKER_01: Plus, broader industry surveillance data.
• 16:44
  SPEAKER_01: High-risk products or a poor compliance history with unresolved warning letters will trigger significantly more frequent and exhaustive inspections.
• 16:52
  SPEAKER_03: Which makes sense.
• 16:53
  SPEAKER_03: But on the flip side, facilities demonstrating strong performance and proactive hazard controls might experience more streamlined oversight.
• 17:00
  SPEAKER_01: Yeah, including remote regulatory assessments and off-site record reviews, which saves everyone a lot of time and money.
• 17:06
  SPEAKER_03: Okay, so navigating all these strict controls, from genomic pathogen testing to global heavy metal tracking, it frankly seems functionally impossible without a truly unified workforce.
• 17:16
  SPEAKER_01: It absolutely is impossible without the right people.
• 17:18
  SPEAKER_03: Which brings us directly to the FDA's strong focus on building a food safety culture.
• 17:23
  SPEAKER_03: The source material emphasizes that a genuine organizational commitment to safety must span from the highest levels of executive leadership all the way down to the newest frontline employees.
• 17:35
  SPEAKER_01: Yes, culture is massive for the FDA right now.
• 17:38
  SPEAKER_03: Facilities must demonstrate this culture through comprehensive training records, frequent internal audits, and documented proactive problem solving.
• 17:46
  SPEAKER_03: And they even provide specific guidance documents to help manufacturers align with these expectations, right?
• 17:51
  SPEAKER_01: Yeah, they have great resources on hazard analysis and preventive controls, traceability records, and sanitation programs for low moisture ready-to-eat foods.
• 18:00
  SPEAKER_03: But here's the thing: culture feels so abstract to me.
• 18:04
  SPEAKER_03: If an FDA inspector walks into a processing plant tomorrow, how do they actually measure or audit something as invisible as culture?
• 18:11
  SPEAKER_01: Culture is not invisible if an auditor knows exactly where to look.
• 18:14
  SPEAKER_03: Okay, what are they looking for?
• 18:15
  SPEAKER_01: Inspectors look for tangible, documented proof of cultural priorities.
• 18:20
  SPEAKER_01: They will examine your training logs to see if education is ongoing and tailored to specific roles, or if it is merely a generic annual video meant to just check a regulatory box.
• 18:31
  SPEAKER_03: The old break room VHS tape approach.
• 18:33
  SPEAKER_01: Exactly.
• 18:33
  SPEAKER_01: That doesn't fly anymore.
• 18:35
  SPEAKER_01: But more importantly, they will analyze your incident reports and corrective action logs.
• 18:40
  SPEAKER_01: These documents are the behavioral artifacts of your culture.
• 18:44
  SPEAKER_03: Behavioral artifacts, I like that term.
• 18:46
  SPEAKER_03: What's an example of that?
• 18:47
  SPEAKER_01: Suppose an inspector sees a detailed record where a frontline employee autonomously halted a massive production line because they noticed a potential allergen cross-contamination issue.
• 18:57
  SPEAKER_03: Which probably cost the company a lot of money in downtime.
• 19:00
  SPEAKER_01: But if executive management documented this action, supported the production delay, and formally recognized the employee for prioritizing safety, that is undeniable, tangible proof of a strong safety culture.
• 19:11
  SPEAKER_03: They put their money where their mouth is.
• 19:13
  SPEAKER_01: Exactly.
• 19:14
  SPEAKER_01: Conversely, if an inspector uncovers chronic, recurring minor sanitation failures that are repeatedly patched with temporary fixes, but never systemically investigated or resolved.
• 19:24
  SPEAKER_01: That demonstrates a toxic culture prioritizing short-term output over long-term safety.
• 19:29
  SPEAKER_01: Culture is ultimately measured by observing how confidently your staff interacts with the equipment and protocols, and whether management's documented actions actually align with their stated safety goals.
• 19:40
  SPEAKER_03: That is a brilliant way to frame it.
• 19:42
  SPEAKER_03: It makes culture totally auditable.
• 19:44
  SPEAKER_01: It really does.
• 19:45
  SPEAKER_03: The ultimate takeaway for food manufacturers here is crystal clear.
• 19:49
  SPEAKER_03: Aligning with the FDA's 2026 priorities is both a regulatory requirement and a fundamental business imperative.
• 19:56
  SPEAKER_01: Absolutely.
• 19:57
  SPEAKER_03: Protecting public health and maintaining consumer brand trust requires dedicated, continuous investments in digital technology, comprehensive workforce training, and incredibly proactive supplier programs.
• 20:08
  SPEAKER_01: I couldn't agree more.
• 20:09
  SPEAKER_01: The shift toward proactive, data-driven food safety management requires a comprehensive operational evaluation.
• 20:16
  SPEAKER_03: You really have to look in the mirror as an organization.
• 20:18
  SPEAKER_01: Yeah, facilities must honestly assess their structural ability to adapt to these evolving expectations because those strategic investments in interoperability and culture, those will be the key differentiators between highly successful operations and those facing costly, devastating recalls.
• 20:42
  SPEAKER_01: It's been great.
• 20:42
  SPEAKER_03: As you look at your own facilities' operational readiness today, consider this final thought.
• 20:47
  SPEAKER_03: If the FDA is already utilizing advanced whole genome sequencing and demanding interoperable digital supply chain tracking right now, how long until AI-driven predictive modeling becomes a mandatory regulatory requirement for your hazard analysis?
• 21:02
  SPEAKER_01: It's definitely coming.
• 21:03
  SPEAKER_03: And the real question is: is your facility's digital infrastructure truly ready for that day?
• 21:10
  SPEAKER_00: Thank you for listening to Through the Line Packaging and Processing.
• 21:13
  SPEAKER_00: You can listen to more episodes on all streaming platforms.
• 21:17
  SPEAKER_00: Be sure to visit us at packworld.com, profoodworld.com, and healthcarepackaging.com for more packaging and processing news.
• 21:26
  SPEAKER_00: This podcast was edited by Bree Guns.